Results 141 to 150 of about 136,109 (177)
Some of the next articles are maybe not open access.
Diabetes Technology & Therapeutics, 2022
No abstract (letter).
A. Vambergue +9 more
semanticscholar +1 more source
No abstract (letter).
A. Vambergue +9 more
semanticscholar +1 more source
Diabetes Research and Clinical Practice, 2011
Iatrogenic hypoglycemia is the limiting factor in the glycemic control of diabetes. It causes recurrent symptomatic and sometimes, at least temporally, disabling episodes in most people with type 1 diabetes, as well as in many with advanced type 2 diabetes.
openaire +2 more sources
Iatrogenic hypoglycemia is the limiting factor in the glycemic control of diabetes. It causes recurrent symptomatic and sometimes, at least temporally, disabling episodes in most people with type 1 diabetes, as well as in many with advanced type 2 diabetes.
openaire +2 more sources
Diabetes, 2022
Introduction: Impaired awareness of hypoglycemia (IAH) is a risk factor for severe hypoglycemia in type 1 diabetes (T1D) . Current tools to identify IAH are limited in their ability to characterize unawareness and evaluate hypoglycemia severity.
Austin Matus +5 more
semanticscholar +1 more source
Introduction: Impaired awareness of hypoglycemia (IAH) is a risk factor for severe hypoglycemia in type 1 diabetes (T1D) . Current tools to identify IAH are limited in their ability to characterize unawareness and evaluate hypoglycemia severity.
Austin Matus +5 more
semanticscholar +1 more source
World Advances in Renal Medicine
Diabetes mellitus (DM) is the leading cause of chronic kidney disease (CKD) worldwide. DM poses a significant health challenge in the Middle East and Oman, as diabetic kidney disease (DKD) represents almost half of the cases of CKD in the country. One of
F. Elias, Ahmed Halawa
semanticscholar +1 more source
Diabetes mellitus (DM) is the leading cause of chronic kidney disease (CKD) worldwide. DM poses a significant health challenge in the Middle East and Oman, as diabetic kidney disease (DKD) represents almost half of the cases of CKD in the country. One of
F. Elias, Ahmed Halawa
semanticscholar +1 more source
Diabetes, 2021
Patients with T1D exhibit a major loss in beta cell mass, associated with low or undetectable circulating markers of beta cell function. C-peptide serves as a biomarker used to assess the residual mass of functional insulin-producing pancreatic beta ...
B. Keymeulen +8 more
semanticscholar +1 more source
Patients with T1D exhibit a major loss in beta cell mass, associated with low or undetectable circulating markers of beta cell function. C-peptide serves as a biomarker used to assess the residual mass of functional insulin-producing pancreatic beta ...
B. Keymeulen +8 more
semanticscholar +1 more source
Unawareness of Hypoglycemia by Insulin-Dependent Diabetics
Hormone and Metabolic Research, 1990After several years of insulin therapy, about 20% of insulin-dependent diabetics have little or no perception of hypoglycaemia because of a loss of the adrenergic warning symptoms. This defect, poorly correlated with the presence of autonomic neuropathy, has been classically explained by a defect in the catecholamine secretion. We compared the hormonal
A, Grimaldi +8 more
openaire +2 more sources
Hypoglycemia Unawareness in IDDM
Diabetes Care, 1993Hypoglycemia unawareness—loss of the neurogenic (autonomic) warning symptoms of developing hypoglycemia—is one of three hypoglycemia-associated clinical syndromes that exemplify hypoglycemia-associated autonomic failure in IDDM. Reduced awareness of developing hypoglycemia (an elevated glycemic threshold for symptoms) is a feature not only of ...
openaire +2 more sources
Hypoglycemia-induced cognitive dysfunction in diabetes mellitus: Effect of hypoglycemia unawareness
Physiology & Behavior, 1995Hypoglycemia results in cognitive dysfunction. The aim of this study was to assess and compare the degree of cognitive dysfunction experienced by insulin-dependent diabetic patients (IDDM) with hypoglycemia unawareness with patients with normal awareness of hypoglycemia.
A E, Gold +3 more
openaire +2 more sources
A potential role for GPR107 in the development of Hypoglycemia Unawareness
PhysiologyDiabetes remains one of the largest health burdens in modern society and while an estimated 37.3 million people suffer from either type 1 or type 2 diabetes worldwide, a further 96 million people are currently estimated to be prediabetic.
Lisa Hagena +4 more
semanticscholar +1 more source
Epinephrine Secretion, Hypoglycemia Unawareness, and Diabetic Autonomic Neuropathy
Annals of Internal Medicine, 1994The failure of some type I diabetic patients to secrete epinephrine and glucagon in response to hypoglycemia has been documented by many investigators, and most studies have confirmed that an inability to secrete these counterregulatory hormones places patients at risk for developing clinical hypoglycemia. Inadequate acute glucose counterregulation can
R D, Hoeldtke, G, Boden
openaire +2 more sources